[1]王琛,李东豪,闻毅颐.玻璃体内注射康柏西普联合周边视网膜选择性光凝治疗视网膜静脉阻塞继发黄斑水肿的疗效及安全性[J].眼科新进展,2016,36(5):471-473.[doi:10.13389/j.cnki.rao.2016.0126]
　WANG Chen,LI Dong-Hao,WEN Yi-Yi.Intravitreal injection of conbercept combined with selective peripheral retinal photocoagulation for macular edema secondary to retinal vein occlusion[J].Recent Advances in Ophthalmology,2016,36(5):471-473.[doi:10.13389/j.cnki.rao.2016.0126]
点击复制

玻璃体内注射康柏西普联合周边视网膜选择性光凝治疗视网膜静脉阻塞继发黄斑水肿的疗效及安全性
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
36卷
期数:
2016年5期
页码:
471-473
栏目:
应用研究
出版日期:
2016-05-05

文章信息/Info

Title:
Intravitreal injection of conbercept combined with selective peripheral retinal photocoagulation for macular edema secondary to retinal vein occlusion
作者:
王琛; 李东豪; 闻毅颐
510150　广东省广州市，广州医科大学附属第三医院眼科
Author(s):
WANG Chen; LI Dong-Hao; WEN Yi-Yi
Department of Ophthalmology, the third Affiliated Hospital of Guangzhou Medical University,Guangzhou 510150,Guangdong Province, China
关键词:
康柏西普; 视网膜静脉阻塞; 黄斑水肿; 视网膜激光光凝
Keywords:
conbercept ;  retinal vein occlusion ;  macular edema ;  retinal photocoagulation
DOI:
10.13389/j.cnki.rao.2016.0126
文献标志码:
A
摘要:
目的　观察玻璃体内注射康柏西普联合周边视网膜选择性光凝治疗视网膜静脉阻塞继发黄斑水肿的疗效及安全性。方法　选择２０１４年３月至２０１５年３月于我院眼科就诊的视网膜静脉阻塞继发黄斑水肿患者２６例２６眼，予以玻璃体内注射康柏西０．５ｍｇ。１周后，根据ＦＦＡ结果，对于周边视网膜存在无灌注区的患者，联合周边视网膜选择性光凝；分别于术后１个月、２个月、３个月进行复查，若黄斑水肿无明显减轻或复发［黄斑中心凹视网膜厚度（ｃｅｎｔｒａｌｍａｃｕｌａｒｔｈｉｃｋｎｅｓｓ，ＣＭＴ）＞２２５μｍ或ＣＭＴ增厚＞１００μｍ］，行重复注射；对比分析患眼治疗前后最佳矫正视力（ｂｅｓｔ-ｃｏｒｒｅｃｔｅｄｖｉｓｕａｌａｃｕｉｔｙ，ＢＣＶＡ）、ＣＭＴ的变化并观察有无眼部或全身并发症。结果　治疗前患眼ＢＣＶＡ为０．０９±０．０５，治疗后１周、１个月、２个月、３个月时ＢＣＶＡ分别为０．１６±０．０６、０．２５±０．０７、０．２１±０．０７、０．２０±０．０８，各时间点与治疗前相比，差异均有统计学意义（ｔ１周＝９．３９２，ｔ１个月＝１４．４４０，ｔ２个月＝９．２９５，ｔ３个月＝６．７０９，均为Ｐ＜０．０５）；治疗前患眼ＣＭＴ为（６０８．５０±１１９．４５）μｍ，治疗后１周、１个月、２个月、３个月ＣＭＴ分别为（３６４．３５±８４．３３）μｍ、（２７９．１２±７９．７３）μｍ、（３０８．００±７７．９０）μｍ、（３２６．７７±９１．７８）μｍ。复查各时间点与术前相比，差异均有统计学意义（ｔ１周＝１１．１２４，ｔ１个月＝１４．６６７，ｔ２个月＝１４．１７６，ｔ３个月＝１３．４３４，均为Ｐ＜０．０５）；随访期间，２６眼均未发生与药物、玻璃体内注射相关的局部及全身的严重不良反应。结论　玻璃体内注射康柏西普联合周边视网膜选择性光凝治疗视网膜静脉阻塞继发黄斑水肿具有较好的疗效及安全性，可以减轻黄斑水肿，提高患者的视力。
Abstract:
Objective To observe the clinical effects and safety of intravitreal injection of conbercept combined with selective peripheral retinal photocoagulation for macular edema secondary to retinal vein occlusion ( RVO-ME) . Methods Twenty-six patients (26 eyes) with RVO-ME from March 2014 to March 2015 in our hospital were retrospectively analyzed. All patients received intravitreal injection of 0. 5 mg conbercept at frrst visit. One week later , according to the FFA ’ s results , patients with non-perfusion area in peripheral retina received selective laser photocoagulation. The best-corrected visual acuity ( BCVA) . central macular thickness ( CMT) were observed before and I month ,2 months .3 months after treatment. Then , the changes in pre-treatment and posttreatment were compared , and the related complications were recorded. Results BCVA before treatment and I week, I month.2 months. 3 months after treatment were 0. 09 + 0. 05 .0. 16 + 0. 06 .0. 25 + 0. 07 , 0. 21 + 0. 07 .0. 20 + 0. 08 , respectively, the posttreatment were higher than pre-treatment ( t, week = 9. 392 , t, morm = 14. 440 , t2 morm s = 9. 295 , t3 mo iths = 6. 709 , all P < 0. 05 ) . The central macular thickness before treatment and I week. I month.2 months, 3 months after treatment were ( 608. 50 + 119. 45 ) ym, ( 364. 35 + 84. 33 ) pm, ( 279. 12 + 79. 73 ) ym , ( 308. 00 +77. 90 ) pm, ( 326. 77 +91. 78 ) ym , respectively , the post-treatment were lower than pre-treatment( t, week = 9. 392 , t, month = 14. 440 , tz months = 9. 295 , t3 morm s = 6. 709 . all P < 0. 05 ) . After treatment , no serious complication was seen. Conclusion The efficacy and safety of intravitreal conbercept combined with selective peripheral retinal photocoagulation for macular edema secondary to retinal vein occlusion are assured.can reduce the macular edema and improve the visual acuity.

相似文献/References:

[1]王刚.曲安奈德联合氪激光治疗视网膜静脉阻塞的临床疗效观察[J].眼科新进展,2013,33(7):000.
[2]马宇 刘意 郭娟 周利晓.金纳多联合血栓通对视网膜静脉阻塞患者同型半胱氨酸水平的影响[J].眼科新进展,2013,33(9):000.
[3]袁子茗 王帅 宋蓓雯 胡健艳 吴强.维速达尔光动力疗法诱导兔视网膜静脉阻塞的实验研究[J].眼科新进展,2012,32(9):000.
[4]李娟娟 李燕.先天性及获得性视盘血管袢的临床观察[J].眼科新进展,2013,33(11):000.
[5]陆秉文 吴星伟.视网膜静脉阻塞黄斑水肿患者玻璃体内注射ranibi-zumab后视野变化[J].眼科新进展,2013,33(12):000.
[6]金昱,石安娜,刘淼. 玻璃体内注射雷珠单抗（Ranibizumab）治疗视网膜静脉阻塞继发黄斑水肿[J].眼科新进展,2014,34(9):855.[doi:10.13389/j.cnki.rao.2014.0236]
[7]张娣,张玲,杨静,等.玻璃体内注射康柏西普联合手术及全视网膜光凝治疗新生血管性青光眼[J].眼科新进展,2015,35(12):1170.[doi:10.13389/j.cnki.rao.2015.0320]
　ZHANG Di,ZHANG Ling,YANG Jing,et al.Intravitreal injection of conbercept combined with operation and panretinal photocoagulation for neovascular glaucoma[J].Recent Advances in Ophthalmology,2015,35(5):1170.[doi:10.13389/j.cnki.rao.2015.0320]
[8]周洁,王宏彬,王文亭.雷珠单抗治疗视网膜静脉阻塞的临床研究[J].眼科新进展,2016,36(1):070.[doi:10.13389/j.cnki.rao.2016.0020]
　ZHOU Jie,WANG Hong-Bin,WANG Wen-Ting.Efficacy of intravitreal injection of ranibizumab for retinal vein occlusion[J].Recent Advances in Ophthalmology,2016,36(5):070.[doi:10.13389/j.cnki.rao.2016.0020]
[9]李娜,张杰,高荣玉,等.单次注射康柏西普治疗渗出型AMD患者RPE隆起面积与容积变化[J].眼科新进展,2016,36(2):172.[doi:10.13389/j.cnki.rao.2016.0047]
　LI Na,ZHANG Jie,GAO Rong-Yu,et al.Changes of retinal pigment epithelium uplift area and volume in exudative age-related macular degeneration after once injection of conbercept[J].Recent Advances in Ophthalmology,2016,36(5):172.[doi:10.13389/j.cnki.rao.2016.0047]
[10]袁牧之,林颖,刘泉.视网膜静脉阻塞患者血浆和泪液中血管内皮生长因子表达的研究[J].眼科新进展,2016,36(5):468.[doi:10.13389/j.cnki.rao.2016.0125]
　YUAN Mu-Zhi,LIN Ying,LIU Quan.Expression of VEGF in plasma and tears of patients with RVO[J].Recent Advances in Ophthalmology,2016,36(5):468.[doi:10.13389/j.cnki.rao.2016.0125]
[11]舒娜,姜波,史春生.视网膜静脉阻塞继发黄斑水肿患者黄斑中心凹下脉络膜厚度变化研究[J].眼科新进展,2021,41(2):154.[doi:10.13389/j.cnki.rao.2021.0032]
　SHU Na,JIANG Bo,SHI Chunsheng.Changes in subfoveal choroidal thickness in eyes with macular edema secondary to retinal vein occlusion[J].Recent Advances in Ophthalmology,2021,41(5):154.[doi:10.13389/j.cnki.rao.2021.0032]
[12]方丽英,黄宝宇,黄敏丽.Ozurdex与康柏西普治疗视网膜静脉阻塞继发黄斑水肿的疗效对比[J].眼科新进展,2021,41(3):231.[doi:10.13389/j.cnki.rao.2021.0048]
　FANG Liying,HUANG Baoyu,HUANG Minli.Comparison of the curative effect of Ozurdex and conbercept in the treatment of macular edema secondary to retinal vein occlusion[J].Recent Advances in Ophthalmology,2021,41(5):231.[doi:10.13389/j.cnki.rao.2021.0048]
[13]朱婷婷,黄丹,张春元,等.玻璃体内注射康柏西普对糖尿病黄斑水肿患者和继发于视网膜静脉阻塞的黄斑水肿患者的疗效差异[J].眼科新进展,2023,43(1):053.[doi:10.13389/j.cnki.rao.2023.0011]
　ZHU Tingting,HUANG Dan,ZHANG Chunyuan,et al.Different efficacies of intravitreal injection of conbercept for diabetic macular edema and macular edema secondary to retinal vein obstruction[J].Recent Advances in Ophthalmology,2023,43(5):053.[doi:10.13389/j.cnki.rao.2023.0011]

更新日期/Last Update: 2016-05-04